Loma Linda University Medical Center – Murrieta has received two recognitions for excellence in stroke care from the American Heart Association/American Stroke Association.
LLUMC – Murrieta was presented with the 2019 Get With The Guidelines® – Stroke Gold Plus and the Target: Stroke Honor Roll Elite Quality Achievement Award from the associations on May 31 during public educational event.
This marks the third year LLUMC – Murrieta has been recognized by the by the American Heart Association/American Stroke Association for quality stroke care.
LLUMC – Murrieta earned the 2019 Get With The Guidelines® – Stroke Gold Plus award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, schedule a follow-up visit and other needed care transition interventions.
LLUMC-Murrieta received the association’s Target: StrokeSMElite award for its quality of operational procedures. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
“We are pleased to recognize Loma Linda University Medical Center – Murrieta for their commitment to stroke care,” said Lee H. Schwamm, M.D., national chairperson of the Quality Oversight Committee and executive vice chair of neurology, director of acute stroke Services at Massachusetts General Hospital. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”